Dale Broadrick, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 1,200 shares at $3.00 ($4K) on 2022-07-13, disclosed to the SEC on 2022-07-15.
Open-market purchase of $4k BRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.38 | 100 | $338 | 9.4% |
| 2 | $2.97 | 900 | $3K | 74.0% |
| 3 | $3.00 | 200 | $600 | 16.6% |
| Total | $3.01 avg | 1,200 | $4K | 100% |
| Filing → |
| BRTX | BUY | 2024-02-09 | $325K | — | Filing → |
| BRTX | SELL | 2023-12-05 | $470 | — | Filing → |
| BRTX | SELL | 2023-12-01 | $525 | — | Filing → |